Source - LSE Regulatory
RNS Number : 6237V
PureTech Health PLC
05 December 2023
 

05 December 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

04 December 2023



Number of ordinary shares purchased:

45,974



Highest price paid per share:

156.00p



Lowest price paid per share:

150.00p



Volume weighted average price paid per share:

152.84p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,835,203 ordinary shares in treasury and has 272,632,956 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,632,956 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

04/12/2023

08:44:20

611

153

CHIX

00380774140TRLO0.1.1

04/12/2023

08:44:20

1222

153

XLON

00380774141TRLO0.1.1

04/12/2023

09:08:12

1222

153.2

XLON

00380776371TRLO0.1.1

04/12/2023

09:08:16

126

152.8

AQXE

00380776374TRLO0.1.1

04/12/2023

09:08:16

71

152.4

BATE

00380776375TRLO0.1.1

04/12/2023

09:08:16

318

152.4

BATE

00380776376TRLO0.1.1

04/12/2023

11:18:21

269

153.2

XLON

00380791041TRLO0.1.1

04/12/2023

11:55:30

475

153.6

CHIX

00380797013TRLO0.1.1

04/12/2023

11:55:30

1222

153.8

XLON

00380797014TRLO0.1.1

04/12/2023

11:55:30

164

153.4

BATE

00380797016TRLO0.1.1

04/12/2023

11:55:30

197

153.4

BATE

00380797015TRLO0.1.1

04/12/2023

11:55:30

52

153.6

CHIX

00380797018TRLO0.1.1

04/12/2023

11:55:30

52

153.6

CHIX

00380797017TRLO0.1.1

04/12/2023

11:55:30

32

153.6

CHIX

00380797019TRLO0.1.1

04/12/2023

11:55:30

99

152.8

TRQX

00380797020TRLO0.1.1

04/12/2023

11:55:30

116

152.8

AQXE

00380797021TRLO0.1.1

04/12/2023

12:05:51

79

153.8

CHIX

00380798920TRLO0.1.1

04/12/2023

12:05:51

345

153.8

CHIX

00380798921TRLO0.1.1

04/12/2023

13:04:24

136

154.6

AQXE

00380807288TRLO0.1.1

04/12/2023

13:33:51

611

156

CHIX

00380812520TRLO0.1.1

04/12/2023

13:33:51

1222

156

XLON

00380812521TRLO0.1.1

04/12/2023

13:33:51

361

155.4

BATE

00380812526TRLO0.1.1

04/12/2023

13:33:51

126

155.8

AQXE

00380812525TRLO0.1.1

04/12/2023

13:33:51

99

154.8

TRQX

00380812527TRLO0.1.1

04/12/2023

14:08:25

187

154.6

TRQX

00380819457TRLO0.1.1

04/12/2023

14:08:25

1222

154.6

XLON

00380819458TRLO0.1.1

04/12/2023

14:08:25

11

154.6

TRQX

00380819459TRLO0.1.1

04/12/2023

14:08:25

611

154.6

CHIX

00380819460TRLO0.1.1

04/12/2023

14:08:25

611

154.6

CHIX

00380819461TRLO0.1.1

04/12/2023

14:08:26

322

154.2

BATE

00380819462TRLO0.1.1

04/12/2023

14:08:26

5

154.2

BATE

00380819463TRLO0.1.1

04/12/2023

14:08:26

6

154.2

BATE

00380819464TRLO0.1.1

04/12/2023

14:08:26

2

154.2

BATE

00380819465TRLO0.1.1

04/12/2023

14:08:26

53

154.2

BATE

00380819466TRLO0.1.1

04/12/2023

14:08:26

306

154.2

BATE

00380819467TRLO0.1.1

04/12/2023

14:08:29

43

154

AQXE

00380819477TRLO0.1.1

04/12/2023

14:17:44

83

154

AQXE

00380821262TRLO0.1.1

04/12/2023

14:17:44

126

154

AQXE

00380821263TRLO0.1.1

04/12/2023

14:17:58

162

154.2

XLON

00380821320TRLO0.1.1

04/12/2023

14:17:58

312

154.2

XLON

00380821321TRLO0.1.1

04/12/2023

14:17:58

544

154.2

XLON

00380821322TRLO0.1.1

04/12/2023

14:18:03

196

154.2

XLON

00380821330TRLO0.1.1

04/12/2023

14:20:06

798

153.8

CHIX

00380821741TRLO0.1.1

04/12/2023

14:20:06

77

153.4

XLON

00380821742TRLO0.1.1

04/12/2023

14:20:06

1756

153.4

XLON

00380821743TRLO0.1.1

04/12/2023

14:28:57

12

154.2

XLON

00380823487TRLO0.1.1

04/12/2023

14:30:59

965

153.6

XLON

00380824523TRLO0.1.1

04/12/2023

14:30:59

149

153.6

XLON

00380824524TRLO0.1.1

04/12/2023

14:30:59

1

153.6

XLON

00380824525TRLO0.1.1

04/12/2023

14:30:59

6

153.6

XLON

00380824526TRLO0.1.1

04/12/2023

14:30:59

712

153.6

XLON

00380824527TRLO0.1.1

04/12/2023

14:31:02

361

153.4

BATE

00380824567TRLO0.1.1

04/12/2023

14:31:29

99

152.8

TRQX

00380824928TRLO0.1.1

04/12/2023

14:41:46

1065

152.8

XLON

00380828806TRLO0.1.1

04/12/2023

14:41:57

5831

152.8

XLON

00380828886TRLO0.1.1

04/12/2023

14:42:24

46

152.8

XLON

00380829243TRLO0.1.1

04/12/2023

14:43:26

1247

152.8

XLON

00380829611TRLO0.1.1

04/12/2023

14:44:08

341

152.8

XLON

00380829917TRLO0.1.1

04/12/2023

14:44:33

126

152.4

AQXE

00380830080TRLO0.1.1

04/12/2023

14:48:33

1222

152.2

XLON

00380831261TRLO0.1.1

04/12/2023

14:48:33

611

152.4

CHIX

00380831260TRLO0.1.1

04/12/2023

14:48:54

99

152

TRQX

00380831537TRLO0.1.1

04/12/2023

14:57:01

973

152.4

XLON

00380834283TRLO0.1.1

04/12/2023

15:05:33

126

152

AQXE

00380837536TRLO0.1.1

04/12/2023

15:05:33

733

152

XLON

00380837537TRLO0.1.1

04/12/2023

15:05:33

750

152

XLON

00380837538TRLO0.1.1

04/12/2023

15:05:33

350

152

XLON

00380837539TRLO0.1.1

04/12/2023

15:05:53

611

151.8

CHIX

00380837629TRLO0.1.1

04/12/2023

15:05:53

361

151.6

BATE

00380837630TRLO0.1.1

04/12/2023

15:05:53

99

151.8

TRQX

00380837631TRLO0.1.1

04/12/2023

15:05:53

611

151.6

XLON

00380837632TRLO0.1.1

04/12/2023

15:05:53

99

151.8

TRQX

00380837633TRLO0.1.1

04/12/2023

15:22:01

611

151.8

XLON

00380843591TRLO0.1.1

04/12/2023

15:28:22

525

151.6

XLON

00380845768TRLO0.1.1

04/12/2023

15:28:22

86

151.8

XLON

00380845769TRLO0.1.1

04/12/2023

15:33:35

867

151.8

XLON

00380847545TRLO0.1.1

04/12/2023

15:33:48

333

151.8

BATE

00380847845TRLO0.1.1

04/12/2023

15:35:11

424

150.4

XLON

00380848451TRLO0.1.1

04/12/2023

15:35:11

542

150.4

XLON

00380848452TRLO0.1.1

04/12/2023

15:55:48

500

152

XLON

00380857262TRLO0.1.1

04/12/2023

15:57:03

520

152

CHIX

00380857720TRLO0.1.1

04/12/2023

15:57:03

55

152.4

CHIX

00380857721TRLO0.1.1

04/12/2023

15:57:24

647

151.6

CHIX

00380857868TRLO0.1.1

04/12/2023

15:57:24

1222

151.6

XLON

00380857867TRLO0.1.1

04/12/2023

16:06:38

1

152

AQXE

00380862368TRLO0.1.1

04/12/2023

16:08:26

722

152

XLON

00380863169TRLO0.1.1

04/12/2023

16:08:34

125

152

AQXE

00380863213TRLO0.1.1

04/12/2023

16:11:54

611

152

XLON

00380864562TRLO0.1.1

04/12/2023

16:13:54

498

151.6

CHIX

00380865960TRLO0.1.1

04/12/2023

16:13:54

1222

151.6

XLON

00380865962TRLO0.1.1

04/12/2023

16:13:59

338

151.6

BATE

00380866050TRLO0.1.1

04/12/2023

16:13:59

23

151.6

BATE

00380866051TRLO0.1.1

04/12/2023

16:13:59

99

151.6

TRQX

00380866052TRLO0.1.1

04/12/2023

16:14:00

171

151.2

XLON

00380866089TRLO0.1.1

04/12/2023

16:14:22

306

151.2

XLON

00380866474TRLO0.1.1

04/12/2023

16:14:51

1

150.8

AQXE

00380866748TRLO0.1.1

04/12/2023

16:14:51

125

150.6

AQXE

00380866749TRLO0.1.1

04/12/2023

16:15:34

164

150

BATE

00380867264TRLO0.1.1

04/12/2023

16:15:34

197

150

BATE

00380867265TRLO0.1.1

04/12/2023

16:29:35

134

151

XLON

00380874032TRLO0.1.1

04/12/2023

16:29:50

365

151

XLON

00380874376TRLO0.1.1

04/12/2023

16:29:50

246

151

XLON

00380874378TRLO0.1.1

04/12/2023

16:29:51

28

151

BATE

00380874406TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFIDFDLSIIV
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Puretech Health PLC (PRTC)

+5.50p (+2.59%)
delayed 16:37PM